EMEA-000342-PIP01-08-M07
Key facts
| Invented name |
Sutent
|
| Active substance |
sunitinib
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0147/2018
|
| PIP number |
EMEA-000342-PIP01-08-M07
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of gastro-intestinal stromal tumours
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Pfizer Limited
Tel. +44 (0)1034 646607
E-mail: pip_enquiries@pfizer.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000342-PIP01-08-M07
|
| Compliance opinion date |
29/06/2018
|
| Compliance outcome |
positive
|